Prados, M. D., Lamborn, K. R., Chang, S., Burton, E., Butowski, N., Malec, M., . . . Kelley, S. K. (2006). Phase 1 study of erlotinib HCl alone and combined with temozolomide in patients with stable or recurrent malignant glioma. Duke University Press.
Citação norma ChicagoPrados, Michael D., et al. Phase 1 Study of Erlotinib HCl Alone and Combined With Temozolomide in Patients With Stable or Recurrent Malignant Glioma. Duke University Press, 2006.
MLA引文Prados, Michael D., et al. Phase 1 Study of Erlotinib HCl Alone and Combined With Temozolomide in Patients With Stable or Recurrent Malignant Glioma. Duke University Press, 2006.
警告：這些引文格式不一定是100％准確.